Jeffrey Cohen
Stock Analyst at Ladenburg Thalmann & Co.
(0.52)
# 4,307
Out of 5,005 analysts
183
Total ratings
33.2%
Success rate
-3%
Average return
Main Sectors:
Stocks Rated by Jeffrey Cohen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NMTC NeuroOne Medical Technologies | Reiterated: Buy | $8 → $8.8 | $1.33 | +561.65% | 3 | Aug 14, 2026 | |
| AORT Artivion | Reiterated: Buy | $42 → $39 | $22.63 | +73.22% | 11 | Aug 7, 2026 | |
| SERV Serve Robotics | Reiterated: Buy | $17 → $15 | $4.45 | +237.08% | 2 | Aug 7, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $31 → $30 | $21.51 | +41.33% | 2 | Jul 30, 2026 | |
| NAGE Niagen Bioscience | Reiterated: Buy | $12 → $11 | $3.05 | +260.66% | 13 | Jul 21, 2026 | |
| NVNO enVVeno Medical | Upgraded: Buy | $30 | $8.67 | +246.02% | 3 | Jul 6, 2026 | |
| LGCY Legacy Education | Reiterated: Buy | $15 → $15 | $9.31 | +65.41% | 6 | May 15, 2026 | |
| CBLL CeriBell | Reiterated: Buy | $32 | $23.69 | +35.08% | 2 | May 12, 2026 | |
| DRTS Alpha Tau Medical | Reiterated: Buy | $18 → $14 | $14.54 | -3.71% | 3 | May 12, 2026 | |
| ECOR electroCore | Reiterated: Buy | $23 → $20 | $11.22 | +76.92% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $66 → $62 | $33.07 | +87.48% | 9 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $9.5 | $13.31 | -28.63% | 8 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $12 | $2.45 | +389.80% | 3 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $3.6 | $0.4856 | n/a | 1 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.2 → $14 | $0.005 | n/a | 6 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $72 → $58 | $27.99 | n/a | 13 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.66 | n/a | 11 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 → $56 | $39.71 | n/a | 8 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $0.6402 | n/a | 6 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 → $27 | $9.44 | n/a | 6 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.25 → $30 | $1.27 | n/a | 2 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3.2 → $1.6 | $1.49 | n/a | 7 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $0.1537 | n/a | 1 | Apr 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.7758 | n/a | 2 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5.4 → $5 | $1.64 | n/a | 5 | Nov 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $1.3 → $3.8 | $0.0001 | n/a | 6 | Oct 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.29 | n/a | 4 | Oct 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $4.39 | n/a | 1 | Sep 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $85 | $2.94 | n/a | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0002 | n/a | 4 | Jan 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $6 | $2.28 | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $22.97 | n/a | 1 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $6.75 | $7.70 | n/a | 2 | Nov 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ILA 5,182 | ILA 4,000 | n/a | 1 | Nov 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 → $21 | $2.05 | n/a | 2 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $8.5 | $0.0003 | n/a | 3 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $15 | $2.28 | n/a | 2 | Apr 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $8.25 | $0.0001 | n/a | 1 | Dec 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $22 | $15.12 | n/a | 3 | Aug 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $40 | $0.0002 | n/a | 3 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.28 | n/a | 2 | Nov 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4.35 | $1.88 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $50 → $100 | $1.81 | n/a | 4 | May 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $55 → $48 | $45.38 | n/a | 2 | Apr 27, 2017 |
NeuroOne Medical Technologies
Aug 14, 2026
Reiterated: Buy
Price Target: $8 → $8.8
Current: $1.33
Upside: +561.65%
Artivion
Aug 7, 2026
Reiterated: Buy
Price Target: $42 → $39
Current: $22.63
Upside: +73.22%
Serve Robotics
Aug 7, 2026
Reiterated: Buy
Price Target: $17 → $15
Current: $4.45
Upside: +237.08%
Beta Bionics
Jul 30, 2026
Reiterated: Buy
Price Target: $31 → $30
Current: $21.51
Upside: +41.33%
Niagen Bioscience
Jul 21, 2026
Reiterated: Buy
Price Target: $12 → $11
Current: $3.05
Upside: +260.66%
enVVeno Medical
Jul 6, 2026
Upgraded: Buy
Price Target: $30
Current: $8.67
Upside: +246.02%
Legacy Education
May 15, 2026
Reiterated: Buy
Price Target: $15 → $15
Current: $9.31
Upside: +65.41%
CeriBell
May 12, 2026
Reiterated: Buy
Price Target: $32
Current: $23.69
Upside: +35.08%
Alpha Tau Medical
May 12, 2026
Reiterated: Buy
Price Target: $18 → $14
Current: $14.54
Upside: -3.71%
electroCore
May 7, 2026
Reiterated: Buy
Price Target: $23 → $20
Current: $11.22
Upside: +76.92%
Mar 4, 2026
Reiterated: Buy
Price Target: $66 → $62
Current: $33.07
Upside: +87.48%
Nov 12, 2025
Reiterated: Buy
Price Target: $13 → $9.5
Current: $13.31
Upside: -28.63%
Nov 12, 2025
Reiterated: Buy
Price Target: $10 → $12
Current: $2.45
Upside: +389.80%
Aug 28, 2025
Initiated Coverage: Buy
Price Target: $3.6
Current: $0.4856
Upside: n/a
Mar 31, 2025
Reiterated: Buy
Price Target: $3.2 → $14
Current: $0.005
Upside: n/a
Mar 27, 2025
Reiterated: Buy
Price Target: $72 → $58
Current: $27.99
Upside: n/a
Nov 15, 2024
Downgraded: Hold
Price Target: n/a
Current: $1.66
Upside: n/a
Nov 8, 2024
Reiterated: Buy
Price Target: $53 → $56
Current: $39.71
Upside: n/a
Sep 24, 2024
Reiterated: Buy
Price Target: $14
Current: $0.6402
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: $52 → $27
Current: $9.44
Upside: n/a
Jun 25, 2024
Reiterated: Buy
Price Target: $3.25 → $30
Current: $1.27
Upside: n/a
May 13, 2024
Reiterated: Buy
Price Target: $3.2 → $1.6
Current: $1.49
Upside: n/a
Apr 5, 2024
Reiterated: Buy
Price Target: $41
Current: $0.1537
Upside: n/a
Nov 8, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.7758
Upside: n/a
Nov 7, 2023
Reiterated: Buy
Price Target: $5.4 → $5
Current: $1.64
Upside: n/a
Oct 9, 2023
Downgraded: Hold
Price Target: $1.3 → $3.8
Current: $0.0001
Upside: n/a
Oct 5, 2023
Downgraded: Hold
Price Target: n/a
Current: $3.29
Upside: n/a
Sep 5, 2023
Initiated Coverage: Buy
Price Target: n/a
Current: $4.39
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $28 → $85
Current: $2.94
Upside: n/a
Jan 23, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Aug 4, 2022
Initiated Coverage: Buy
Price Target: $6
Current: $2.28
Upside: n/a
May 2, 2022
Initiated Coverage: Buy
Price Target: $12
Current: $22.97
Upside: n/a
Nov 18, 2021
Reiterated: Buy
Price Target: $11 → $6.75
Current: $7.70
Upside: n/a
Nov 17, 2021
Reiterated: Buy
Price Target: ILA 5,182
Current: ILA 4,000
Upside: n/a
Nov 4, 2021
Reiterated: Buy
Price Target: $11 → $21
Current: $2.05
Upside: n/a
Aug 9, 2021
Reiterated: Buy
Price Target: $12 → $8.5
Current: $0.0003
Upside: n/a
Apr 30, 2021
Reiterated: Buy
Price Target: $25 → $15
Current: $2.28
Upside: n/a
Dec 17, 2020
Initiated Coverage: Buy
Price Target: $8.25
Current: $0.0001
Upside: n/a
Aug 27, 2020
Reiterated: Buy
Price Target: $15 → $22
Current: $15.12
Upside: n/a
Dec 3, 2019
Upgraded: Buy
Price Target: $40
Current: $0.0002
Upside: n/a
Nov 19, 2018
Downgraded: Hold
Price Target: n/a
Current: $1.28
Upside: n/a
Nov 27, 2017
Downgraded: Hold
Price Target: $4.35
Current: $1.88
Upside: n/a
May 18, 2017
Upgraded: Buy
Price Target: $50 → $100
Current: $1.81
Upside: n/a
Apr 27, 2017
Downgraded: Hold
Price Target: $55 → $48
Current: $45.38
Upside: n/a